Calimmune Inc.

The Tucson biotech startup co-founded by UA alumnus Louis Breton in 2006, was acquired in September 2017 by Australia-based CSL Ltd. for $91 million up front and a potential $325 million in performance payments if Calimmune hit milestones including clinical trials for its stem-cell gene therapy to strengthen patients’ own immune systems.